What is the recommended azithromycin dosage for acute upper respiratory infection in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Azithromycin Dosing for Acute Upper Respiratory Tract Infection

For acute upper respiratory tract infections (URTIs), azithromycin is dosed at 500 mg once daily for 3 days in adults, or 10 mg/kg once daily for 3 days in children ≥6 months old. This represents the FDA-approved and guideline-supported regimen for bacterial URTIs including acute bacterial sinusitis and certain pharyngeal infections 1.

Adult Dosing

The standard adult dose is 500 mg orally once daily for 3 consecutive days 1. This 3-day regimen provides equivalent efficacy to longer courses of other antibiotics while improving compliance and reducing adverse effects 2, 3.

Alternative Adult Regimens:

  • 5-day regimen: 500 mg on day 1, then 250 mg daily on days 2-5 (also FDA-approved for community-acquired pneumonia and pharyngitis) 1
  • The 3-day course is preferred for acute bacterial sinusitis specifically 4

Important caveat: Azithromycin should NOT be used as first-line therapy for acute bacterial rhinosinusitis. Guidelines recommend amoxicillin-clavulanate as the preferred agent due to concerns about resistance patterns, particularly with Streptococcus pneumoniae 5. Azithromycin is reserved for patients with β-lactam allergies 4.

Pediatric Dosing (≥6 months old)

For children with acute bacterial sinusitis or otitis media, the recommended dose is 10 mg/kg once daily for 3 days (maximum 500 mg/day) 1, 6.

Specific Pediatric Regimens by Indication:

Acute Bacterial Sinusitis:

  • 10 mg/kg once daily for 3 days 1

Acute Otitis Media (three options):

  • Single-dose: 30 mg/kg as a single dose 1
  • 3-day: 10 mg/kg once daily for 3 days 1
  • 5-day: 10 mg/kg on day 1, then 5 mg/kg daily on days 2-5 1

Pharyngitis/Tonsillitis:

  • 12 mg/kg once daily for 5 days (ages ≥2 years) 1
  • For group A streptococcal pharyngitis, higher total doses (60 mg/kg per course) show superior bacterial eradication compared to 30 mg/kg courses 7

Practical Pediatric Dosing Table (3-day regimen):

Weight Dose per day Total course
5 kg (11 lbs) 2.5 mL (100 mg/5 mL suspension) 150 mg
10 kg (22 lbs) 5 mL 300 mg
20 kg (44 lbs) 5 mL (200 mg/5 mL suspension) 600 mg
30 kg (66 lbs) 7.5 mL 900 mg
≥40 kg (88 lbs) 10 mL 1200 mg

1

Critical Clinical Considerations

When Azithromycin is NOT Appropriate:

  • Common cold/viral URI: Antibiotics are never indicated 5, 8
  • Influenza: Use antivirals, not antibiotics 8
  • First-line acute bacterial rhinosinusitis: Use amoxicillin-clavulanate instead 5
  • Uncomplicated pharyngitis without confirmed streptococcal infection: Avoid empiric antibiotics 9

When to Consider Azithromycin:

  • β-lactam allergy in patients requiring antibiotics for confirmed bacterial URTI 4
  • Atypical pneumonia pathogens (Mycoplasma, Chlamydophila) 6
  • Confirmed group A streptococcal pharyngitis in penicillin-allergic patients 6

Resistance Concerns:

The predicted bacteriologic efficacy of azithromycin for acute bacterial rhinosinusitis is only 77-81% in adults and 78-80% in children, significantly lower than high-dose amoxicillin-clavulanate (90-92%) 4. This reflects increasing macrolide resistance in S. pneumoniae and limited coverage of β-lactamase-producing H. influenzae and M. catarrhalis.

Administration:

  • Can be taken with or without food 1
  • No dosage adjustment needed for renal impairment (GFR >10 mL/min), but use caution in severe renal impairment 1
  • Avoid concurrent aluminum/magnesium-containing antacids (reduces absorption) 10

Adverse Effects:

Most common are gastrointestinal (diarrhea 4-7%, nausea 3-5%, abdominal pain 2-5%) 1. In pediatric studies, discontinuation rates due to adverse effects were approximately 1% 1. The 3-day regimen shows better tolerability than longer courses of comparator antibiotics 3, 11.

Monitoring:

Patients should show clinical improvement within 48-72 hours. Failure to improve warrants reevaluation and consideration of alternative diagnoses or resistant pathogens 6, 4.

References

Guideline

antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Research

Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.